from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1061/-

LFCtreatmentdescriptionclass of inhibitor

0.798

Amikacinug/mL Amikacintranslation

-0.078

Cap5-10ug/mL Capreomycintranslation

0.875

Rox10-50 ug/mL Roxithromycintranslation

0.076

SM2-5 ug/mL Streptomycintranslation

-0.940

Tet5-10 ug/mL Tetracyclinetranslation

0.621

Rif0.2-5ug/mL Rifampicintranscription

-0.056

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.412

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.199

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.625

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.753

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.801

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.378

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.064

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.740

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.363

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.054

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.146

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.225

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.048

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.172

KCN5-20 ug/mL Potassium cyaniderespiration

-1.092

NaN30.2-2 mM Sodium aziderespiration

-1.409

Nigericin50 uM Nigericinrespiration

-0.041

TRC10-150 ug/mL Triclosanrespiration

-0.183

TRZ10-25 ug/mL Thioridazinerespiration

0.810

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.069

menadione6-10 ug/mL Menadionerespiration

0.222

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.068

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.609

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.274

NRP_1Non-replicating persistence stage 1dosRassociated

-0.348

Amp0.2mg/mL AmpicillincellWall

-0.201

Cephalexin20-100 ug/mL CephalexincellWall

0.148

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.429

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.157

EMB10-20 ug/mL EthambutolcellWall

0.112

Eta12-40 ug/mL EthionamidecellWall

0.187

INH0.2-0.4 ug/mL IsoniazidcellWall

0.392

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.698

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.765

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.363

BZA0.12 mg/mL BenzamidearomaticAmides

0.393

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.120

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.391

H2O24 mM hydrogen peroxideDNAdamaging

-0.059

Levo10 ug/mL LevofloxacinDNAdamaging

-0.025

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.694

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.276

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.014

UVUV-irradiationDNAdamaging

-1.265

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.090

Antimycin12.5-50 ug/mL Antimycin A?

-0.923

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.026

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.603

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.100

PA8240.2-2 ug/mL PA-824?

-0.496

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.580

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.829

Verapamil50 uM Verapamil?

-0.186

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.039

methoxatin10-20 ug/mL Methoxatin?